Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

191P - Lung cancer care in Europe during COVID-19: Findings from a global survey of patient experience


03 Apr 2022


Poster Display session


COVID-19 and Cancer

Tumour Site

Thoracic Malignancies


Jackie Fenemore


Annals of Oncology (2022) 33 (suppl_2): S117-S121. 10.1016/annonc/annonc858


J. Fenemore

Author affiliations

  • Global Lung cancer coalition, Manchester/GB

Abstract 191P


The Global Lung Cancer Coalition (GLCC), a partnership of 42 patient organisations across 30 nations, surveyed lung cancer patients to understand the impact of the COVID-19 pandemic on their experience of care. The global online survey examined how care pathways had changed, and how this affected patients’ communication with their medical team.


A multi-national steering group of patients, clinicians and advocates devised questions to explore: How easy patients found it to contact their medical team Whether patients had continued attending appointments in person Whether patients had experienced virtual consultations, and their view of them if so Questions were translated into multiple languages. GLCC members distributed the survey via emails and social media. Results were collated and analysed by the steering group. The GLCC produced a global report with findings for all participating countries, as well as bespoke reports for each country comparing national findings to the global picture.


Responses were received from 10 European nations: Bulgaria, Denmark, Greece, Ireland, Italy, Netherlands, Portugal, Spain, Sweden, and the UK. 494 of the 1,291 responding patients were from Europe (38%). Headline findings for Europe include: Many patients said there was no difference in how easy it was to contact their medical team. A proportion in almost all countries had found contact harder and some patients said they held back because their team was so busy Most patients had been able to see their medical team in person, but the majority in most countries also had telephone appointments. A smaller proportion of patients in only some countries had video calls The majority of patients in all countries prefer in person appointments, but many liked not having to travel to hospital. A small proportion found them difficult or said they wished to stop.


Conclusion As healthcare systems recover from COVID-19, lung cancer patients’ perspectives on virtual consultations must be considered to ensure they work for everyone, with alternatives and support available for those who find video or telephone difficult. All patients should be encouraged to contact their medical team when they need them, despite the pandemic.

Editorial acknowledgement

Authors: Jackie Fenemore: Lung Cancer Nursing UK Maureen Rigney: G02 Foundation for Lung Cancer Win Boerckel: Cancer Care Merel Hennink: Longkanker Nederland Aoife McNamara: Irish Cancer Society Javi Mayans: Asociación Española de Afectados por el Cáncer de Pulmón Bernard Gaspar: Asociación Española de Afectados por el Cáncer de Pulmón Lauren Pretorius: Campaigning for Cancer Micaela Daniels: Campaigning for Cancer Jesme Fox: Roy Castle Lung Cancer Foundation.

Legal entity responsible for the study

The author.


Global Lung Cancer Coalition.


The author has declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.